Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,089 | 314 | 96.9% |
| Education | $129.89 | 2 | 3.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $448.74 | 30 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $397.71 | 31 | $0 (2024) |
| Novo Nordisk Inc | $393.92 | 21 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $319.39 | 43 | $0 (2021) |
| ABBVIE INC. | $319.02 | 15 | $0 (2024) |
| PFIZER INC. | $229.17 | 31 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $188.39 | 12 | $0 (2024) |
| Mylan Specialty L.P. | $173.29 | 8 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $154.60 | 11 | $0 (2019) |
| Amgen Inc. | $151.84 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $415.98 | 22 | ABBVIE INC. ($75.69) |
| 2023 | $631.71 | 34 | ABBVIE INC. ($150.54) |
| 2022 | $499.01 | 26 | Novo Nordisk Inc ($123.23) |
| 2021 | $48.52 | 3 | AbbVie Inc. ($37.36) |
| 2020 | $436.69 | 30 | AstraZeneca Pharmaceuticals LP ($70.97) |
| 2019 | $723.12 | 76 | Merck Sharp & Dohme Corporation ($131.20) |
| 2018 | $755.26 | 68 | Merck Sharp & Dohme Corporation ($112.60) |
| 2017 | $708.97 | 57 | Lilly USA, LLC ($122.31) |
All Payment Transactions
316 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/15/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Biological | ||||||
| 10/07/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 09/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.53 | General |
| Category: NEUROSCIENCE | ||||||
| 07/30/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $26.85 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 07/23/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: PAIN | ||||||
| 07/16/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $27.53 | General |
| Category: Biological | ||||||
| 06/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Diabetes | ||||||
| 06/12/2024 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Neurology | ||||||
| 06/11/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.78 | General |
| Category: PSYCHIATRY | ||||||
| 05/28/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Diabetes | ||||||
| 05/13/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.40 | General |
| 05/01/2024 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: Neurology | ||||||
| 04/23/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Neurology | ||||||
| 03/26/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.29 | General |
| 03/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: DIABETES | ||||||
| 02/13/2024 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Neurology | ||||||
| 02/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.77 | General |
| Category: NEUROSCIENCE | ||||||
| 01/23/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: Inflammation | ||||||
| 01/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Gastroenterology | ||||||
| 11/28/2023 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Neurology | ||||||
| 11/15/2023 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 11/14/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,127 | 2,617 | $353,026 | $118,471 |
| 2022 | 18 | 1,308 | 3,178 | $411,802 | $137,749 |
| 2021 | 19 | 1,282 | 2,867 | $413,897 | $136,411 |
| 2020 | 17 | 1,502 | 3,315 | $253,652 | $119,327 |
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 171 | 537 | $100,419 | $31,322 | 31.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 199 | 369 | $102,213 | $29,953 | 29.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 32 | 333 | $30,303 | $15,093 | 49.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 114 | 114 | $32,832 | $14,233 | 43.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 54 | 54 | $23,544 | $8,638 | 36.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 211 | 404 | $8,080 | $3,327 | 41.2% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 41 | 41 | $10,263 | $3,260 | 31.8% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 27 | 96 | $7,872 | $3,081 | 39.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 36 | 259 | $15,281 | $2,583 | 16.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 16 | $5,936 | $1,882 | 31.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 24 | 24 | $3,148 | $1,819 | 57.8% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 22 | 23 | $1,840 | $796.26 | 43.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 26 | 26 | $988.00 | $776.88 | 78.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 42 | 66 | $4,290 | $618.80 | 14.4% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 12 | 23 | $1,081 | $373.06 | 34.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 12 | 12 | $456.00 | $358.56 | 78.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 67 | 100 | $2,200 | $217.80 | 9.9% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 22 | 120 | $2,280 | $139.43 | 6.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 208 | 433 | $119,941 | $35,899 | 29.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 192 | 590 | $110,330 | $35,673 | 32.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 55 | 454 | $41,314 | $20,243 | 49.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 92 | 92 | $26,496 | $11,498 | 43.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 48 | 48 | $20,928 | $7,851 | 37.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 45 | 56 | $20,776 | $7,234 | 34.8% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 44 | 166 | $13,612 | $6,040 | 44.4% |
About Dr. Charles Holt, DO
Dr. Charles Holt, DO is a Family Medicine healthcare provider based in Tooele, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1689772519.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Charles Holt, DO has received a total of $4,219 in payments from pharmaceutical and medical device companies, with $415.98 received in 2024. These payments were reported across 316 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($4,089).
As a Medicare-enrolled provider, Holt has provided services to 5,219 Medicare beneficiaries, totaling 11,977 services with total Medicare billing of $511,959. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Tooele, UT
- Active Since 09/21/2006
- Last Updated 11/01/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1689772519
Products in Payments
- FARXIGA (Drug) $299.03
- VRAYLAR (Drug) $294.35
- JANUVIA (Drug) $265.15
- Ozempic (Drug) $245.71
- TRADJENTA (Drug) $164.98
- JARDIANCE (Drug) $151.17
- ELIQUIS (Drug) $142.50
- TRULICITY (Drug) $131.27
- Sunosi (Drug) $126.31
- SOLIQUA (Drug) $113.90
- MOUNJARO (Drug) $97.73
- YUPELRI (Drug) $90.27
- XIFAXAN (Drug) $87.17
- REXULTI (Drug) $86.40
- Yupelri (Drug) $83.02
- APLENZIN (Drug) $67.83
- Veozah (Drug) $66.23
- CHANTIX (Drug) $61.63
- VYVANSE (Drug) $61.27
- FREESTYLE LIBRE 2 (Device) $55.99
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Tooele
Russell Anderson, D.o, D.O
Family Medicine — Payments: $71,572
Dr. Carolyn Forbes, M.d, M.D
Family Medicine — Payments: $8,459
Blake Beazer, Md, MD
Family Medicine — Payments: $7,998
Sergio Abarca, M.d, M.D
Family Medicine — Payments: $7,442
Dr. Spencer Larson, Do, DO
Family Medicine — Payments: $873.84
Nicole Patrone, Md, MD
Family Medicine — Payments: $225.54